Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Hims & Hers Health Inc (NYSE: HIMS) closed the day trading at $41.98 down -34.63%% from the previous closing price of $64.22. In other words, the price has decreased by -$34.63% from its previous closing price. On the day, 172.09 million shares were traded. HIMS stock price reached its highest trading level at $48.35 during the session, while it also had its lowest trading level at $41.97.
Ratios:
For a better understanding of HIMS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 39.94. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 04, 2025, Needham reiterated its Buy rating and also lowered its target price recommendation from $61 to $65.
TD Cowen Downgraded its Buy to Hold on April 29, 2025, while the target price for the stock was maintained at $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 23 ’25 when Oluyemi Okupe bought 69,431 shares for $41.98 per share.
Chi Michael sold 17,102 shares of HIMS for $1,021,844 on Jun 17 ’25. The Chief Commercial Officer now owns 278,654 shares after completing the transaction at $59.75 per share. On Jun 16 ’25, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 128,127 shares for $56.76 each. As a result, the insider received 7,271,950 and left with 160,215 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 14374455296 and an Enterprise Value of 9137160192. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.11, and their Forward P/E ratio for the next fiscal year is 43.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.27 while its Price-to-Book (P/B) ratio in mrq is 17.09. Its current Enterprise Value per Revenue stands at 5.121 whereas that against EBITDA is 66.366.
Stock Price History:
The Beta on a monthly basis for HIMS is 2.10, which has changed by 0.812608 over the last 52 weeks, in comparison to a change of 0.10163462 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is -11.54%, while the 200-Day Moving Average is calculated to be 25.46%.
Shares Statistics:
Over the past 3-months, HIMS traded about 40.04M shares per day on average, while over the past 10 days, HIMS traded about 49180020 shares per day. A total of 215.21M shares are outstanding, with a floating share count of 190.51M. Insiders hold about 14.88% of the company’s shares, while institutions hold 70.32% stake in the company. Shares short for HIMS as of 1748563200 were 60880774 with a Short Ratio of 1.52, compared to 1745971200 on 62308786. Therefore, it implies a Short% of Shares Outstanding of 60880774 and a Short% of Float of 33.78.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
